AdipoGen Life Sciences

TEPP46 [ML-265]

CHF 50.00
In stock
AG-CR1-3687-M0011 mgCHF 50.00
AG-CR1-3687-M0055 mgCHF 120.00
AG-CR1-3687-M02525 mgCHF 420.00
More Information
Product Details
Synonyms TEPP-46; ML265; NCGC00186528; CID-44246499
Product Type Chemical
Properties
Formula

C17H16N4O2S2

MW 372.5
CAS 1221186-53-3
Purity Chemicals ≥95%
Appearance White to off-white solid.
Solubility Soluble in DMSO (10mg/ml). Insoluble in water.
Identity Determined by 1H-NMR
InChi Key ZWKJWVSEDISQIS-UHFFFAOYSA-N
Smiles CS(C1=CC(N2C)=C(C3=C2C(N(N=C3)CC4=CC(N)=CC=C4)=O)S1)=O
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage -20°C
Use/Stability Stable for at least 2 years after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description
  • Potent and selective cell permeable pyruvate kinase M2 (PKM2) activator with little or no activity versus PKM1, PKL and PKR.
  • Useful agent for immunometabolism research.
  • Anticancer (reducing tumor sizes in mice) and anti-inflammatory agent.
  • Shown to bind the enzyme PKM2 to promote formation of stable, enzymatically-active tetramers, thereby promoting the last rate-limiting step of glycolysis, converting PEP to pyruvate. In addition, it prevents PKM2 translocation to the nucleus resulting in reduced glycolysis and HIF-1α activation, causing diminished Warburg effect and IL-1β production.
Product References
  1. J.K. Jiang et al. Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase: J.K. Jiang, et al.; Bioorg. Med. Chem. Lett. 20, 3387 (2010)
  2. ML265: A potent PKM2 activator induces tetramerization and reduces tumor formation and size in a mouse xenograft model: M.J. Walsh, et al.; Probe Rep. NIH Mol. Libr. Prog. (2012)
  3. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis: D. Anastasiou, et al.; Nat. Chem. Biol. 8, 839 (2012)
  4. Pyruvate Kinase M2 regulates HIF-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages: E.M. Palsson-McDermott, et al.; Cell Metab. 21, 65 (2015)
  5. A guide to immunometabolism for immunologists: L.A. O'Neill, et al.; Nat. Rev. Immunol. 16, 553 (2016)
  6. Pyruvate Kinase M2: A Potential Target for Regulating Inflammation: J.C. Alves-Filho & E.M. Palsson-McDermott; Front. Immunol. 7, 145 (2016) (Review)
  7. Similarities and Distinctions of Cancer and Immune Metabolism in Inflammation and Tumors: G. Andrejeva & J.C. Rathmell; Cell Metab. 26, 49 (2017)
  8. Targeting metabolism as a novel therapeutic approach to autoimmunity, inflammation and transplantation: I.A. Bettencourt & J.D. Powell; J. Immunol. 198, 999 (2017)
  9. Caloric Restriction Mimetic 2-Deoxyglucose Alleviated Inflammatory Lung Injury via Suppressing Nuclear Pyruvate Kinase M2-Signal Transducer and Activator of Transcription 3 Pathway: K. Hu, et al.; Front. Immunol. 9, 426 (2018)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.